People · Operator
Named in public records as an officer, director or promoter · active 2019–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Therapeutics Inc. | — | Biotechnology | Series C | $189.2M | $1.0B | 2019 |
Stacy J. Kanter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stacy J. Kanter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joel Marcus | 1 | 9 |
| Franklin Berger | 1 | 7 |
| Joel S. Marcus | 1 | 3 |
| Jay S. Skyler | 1 | 2 |
| Les Funtleyder | 1 | 1 |
| Shoshana Shendelman | 1 | 1 |
| Teena J. Lerner | 1 | 1 |
| Mark Vignola | 1 | 1 |
| Teena Lerner | 1 | 1 |
| Riccardo Perfetti | 1 | 1 |
| Adam Hansard | 1 | 1 |
| Catherine Thorpe | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.